Paradigm Capital Management LLC NV Purchases New Position in Merck KGaA $MKGAF

Paradigm Capital Management LLC NV acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAFFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 28,084 shares of the company’s stock, valued at approximately $3,609,000. Merck KGaA comprises about 3.1% of Paradigm Capital Management LLC NV’s portfolio, making the stock its 7th biggest holding.

A number of other institutional investors have also recently bought and sold shares of MKGAF. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in Merck KGaA in the second quarter valued at approximately $942,087,000. Cibc World Market Inc. bought a new position in shares of Merck KGaA during the second quarter worth $186,005,000. Madison Wealth Partners Inc bought a new position in shares of Merck KGaA during the second quarter worth $1,031,000. Keating Financial Advisory Services Inc. acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $592,000. Finally, August Group Capital Ltd acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $390,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

Merck KGaA Price Performance

MKGAF opened at $163.45 on Tuesday. The stock has a market cap of $21.12 billion, a P/E ratio of 24.95 and a beta of 0.96. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a fifty day simple moving average of $162.78 and a 200 day simple moving average of $148.59.

Merck KGaA Profile

(Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Further Reading

Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAFFree Report).

Institutional Ownership by Quarter for Merck KGaA (OTCMKTS:MKGAF)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.